Calbindin 2 (CALB2) (N-Term) Peptide
CALB2
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN974398
Quick Overview for Calbindin 2 (CALB2) (N-Term) Peptide (ABIN974398)
Target
Calretinin (CALB2)
(Calbindin 2 (CALB2))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- N-Term
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-CALB2 antibody (Catalog #: ARP58600_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
Calbindin 2 (CALB2) peptide
CALB2 Reactivity: Human, Mouse, Rat, Cow, Pig Host: Synthetic BP, Imm
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- Calretinin (CALB2) (Calbindin 2 (CALB2))
-
Background
-
CALB2 is an intracellular calcium-binding protein belonging to the troponin C superfamily. Members of this protein family have six EF-hand domains which bind calcium. This gene encodes an intracellular calcium-binding protein belonging to the troponin C superfamily. Members of this protein family have six EF-hand domains which bind calcium. Three alternatively spliced transcript variants that encode different proteins have been described.
Alias Symbols: CAL2, CR, CAB29
Protein Interaction Partner: KRT1,TUBA4A
Protein Size: 271 -
Molecular Weight
- 30 kDa
-
Gene ID
- 794
-
NCBI Accession
- NM_001740, NP_001731
-
UniProt
- P22676
Target
-
You are here:
